KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Interest & Investment Income (2016 - 2018)

Historic Interest & Investment Income for Emergent BioSolutions (EBS) over the last 10 years, with Q3 2018 value amounting to $701000.0.

  • Emergent BioSolutions' Interest & Investment Income rose 1004.71% to $701000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.4 million, marking a year-over-year decrease of 2619.55%. This contributed to the annual value of $1.8 million for FY2017, which is 6647.67% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Interest & Investment Income of $701000.0 as of Q3 2018, which was up 1004.71% from $306000.0 recorded in Q2 2018.
  • Over the past 5 years, Emergent BioSolutions' Interest & Investment Income peaked at $701000.0 during Q3 2018, and registered a low of $31000.0 during Q2 2014.
  • For the 5-year period, Emergent BioSolutions' Interest & Investment Income averaged around $259263.2, with its median value being $219000.0 (2016).
  • In the last 5 years, Emergent BioSolutions' Interest & Investment Income surged by 95555.56% in 2014 and then plummeted by 4751.29% in 2018.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Interest & Investment Income stood at $190000.0 in 2014, then plummeted by 40.53% to $113000.0 in 2015, then skyrocketed by 155.75% to $289000.0 in 2016, then plummeted by 44.64% to $160000.0 in 2017, then surged by 338.12% to $701000.0 in 2018.
  • Its Interest & Investment Income was $701000.0 in Q3 2018, compared to $306000.0 in Q2 2018 and $222000.0 in Q1 2018.